Literature DB >> 25795290

Comparison of F-18 FDG-PET/CT and Tc-99m MIBI in the preoperative evaluation of cold thyroid nodules in the same patient group.

Sait Sager1, Betul Vatankulu, Ezgi Erdogan, Sanem Mut, Serkan Teksoz, Tulin Ozturk, Kerim Sonmezoglu, Bedii Kanmaz.   

Abstract

Recent studies have reported that standardized uptake values of FDG-PET imaging might predict malignant thyroid nodules and can be used in the preoperative evaluation of thyroid lesions. The aim of our study was to evaluate FDG-PET imaging in patients with cold thyroid nodules and to compare the imaging findings with Tc-99m MIBI scans and with post-op histopathology results. Twenty-three patients (18F, 5M) with 24 nodules that were suspicious in ultrasound and cold in Tc-99m pertechnetate scan, were included in the study. Each nodule underwent sonographically guided fine-needle aspiration biopsy. FDG-PET and MIBI scans were performed with an interval of 3-5 days. All patients underwent thyroidectomy and their FDG-PET, and MIBI thyroid scan results were compared with post-thyroidectomy pathology results. Post-op histopathology results found 7 malignant and 17 benign nodules. Six of the seven malignant nodules had increased uptake, which were positive for malignancy in both PET and MIBI scans. Each imaging method used different radiopharmaceuticals but showed one false-negative result in two different patients. FDG-PET produced false positives in eight nodules and MIBI scans found false positives in four nodules. FDG-PET imaging and MIBI scan showed the same sensitivity in malignant nodule evaluation, but their specificity differed. As a result, we suggest that FDG-PET imaging is not superior to MIBI scanning in differentiating malignant from benign thyroid nodules. MIBI imaging should be the first choice in the preoperative evaluation of patients with cold thyroid nodules as an adjunct procedure to FNAB because of its low cost and availability. This imaging technique can be used routinely in patients who are reluctant to undergo FNAB.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25795290     DOI: 10.1007/s12020-015-0580-3

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  31 in total

1.  Evaluation of thyroid nodules--combined use of (99m)Tc-methylisobutylnitrile scintigraphy and aspiration cytology to assess risk of malignancy and stratify patients for surgical or nonsurgical therapy--a retrospective cohort study.

Authors:  Gudrun Leidig-Bruckner; Gerd Cichorowski; Peter Sattler; Thomas Bruckner; Bernd Sattler
Journal:  Clin Endocrinol (Oxf)       Date:  2012-05       Impact factor: 3.478

2.  Diagnostic yield of nondiagnostic thyroid nodules is not altered by timing of repeat biopsy.

Authors:  Carrie C Lubitz; Sushruta S Nagarkatti; William C Faquin; Anthony E Samir; Maria C Hassan; Giuseppe Barbesino; Douglas S Ross; Gregory W Randolph; Randall D Gaz; Antonia E Stephen; Richard A Hodin; Gilbert H Daniels; Sareh Parangi
Journal:  Thyroid       Date:  2012-06       Impact factor: 6.568

3.  Role of 99mTc-Tetrofosmin delayed scintigraphy and color Doppler sonography in characterization of solitary thyroid nodules.

Authors:  Rajnish Sharma; Kanti Lal Chakravarty; Madhvi Tripathi; Aruna Kaushik; Pooja Bharti; Maheswar Sahoo; Mahender Kumar Chopra; Harish Rawat; Anil Misra; Anupam Mondal; Ravi Kashyap
Journal:  Nucl Med Commun       Date:  2007-11       Impact factor: 1.690

4.  Incidental thyroid "PETomas": clinical significance and novel description of the self-resolving variant of focal FDG-PET thyroid uptake.

Authors:  Hidefumi Nishimori; Roger Tabah; Marc Hickeson; Jacques How
Journal:  Can J Surg       Date:  2011-04       Impact factor: 2.089

5.  Technetium-99m tetrofosmin imaging in thyroid diseases: comparison with Tc-99m-pertechnetate, thallium-201 and Tc-99m-methoxyisobutylisonitrile scans.

Authors:  M Klain; S Maurea; A Cuocolo; A Colao; L Marzano; G Lombardi; M Salvatore
Journal:  Eur J Nucl Med       Date:  1996-12

6.  Hürthle cell tumor dwelling in hot thyroid nodules: preoperative detection with technetium-99m-MIBI dual-phase scintigraphy.

Authors:  A Vattimo; P Bertelli; M Cintorino; L Burroni; D Volterrani; A Vella; S Lazzi
Journal:  J Nucl Med       Date:  1998-05       Impact factor: 10.057

Review 7.  Cancer treatment and survivorship statistics, 2012.

Authors:  Rebecca Siegel; Carol DeSantis; Katherine Virgo; Kevin Stein; Angela Mariotto; Tenbroeck Smith; Dexter Cooper; Ted Gansler; Catherine Lerro; Stacey Fedewa; Chunchieh Lin; Corinne Leach; Rachel Spillers Cannady; Hyunsoon Cho; Steve Scoppa; Mark Hachey; Rebecca Kirch; Ahmedin Jemal; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2012-06-14       Impact factor: 508.702

8.  Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma.

Authors:  Annick Van den Bruel; Alex Maes; Tom De Potter; Luc Mortelmans; Maria Drijkoningen; Bo Van Damme; Pierre Delaere; Roger Bouillon
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

9.  Combined (99m)Tc-methoxyisobutylisonitrile scintigraphy and fine-needle aspiration cytology offers an accurate and potentially cost-effective investigative strategy for the assessment of solitary or dominant thyroid nodules.

Authors:  Anita Wale; Kenneth A Miles; Barnaby Young; Charles Zammit; Anthony Williams; John Quin; Sabina Dizdarevic
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-13       Impact factor: 9.236

10.  Imaging of the thyroid: Recent advances.

Authors:  Vikas Chaudhary; Shahina Bano
Journal:  Indian J Endocrinol Metab       Date:  2012-05
View more
  2 in total

1.  Accessing the influence of 99mTc-Sesta-MIBI-positive thyroid nodules on preoperative localisation studies in patients with primary hyperparathyroidism.

Authors:  Lindsay Hargitai; Maria Schefner; Tatjana Traub-Weidinger; Alexander Haug; Melisa Arikan; Christian Scheuba; Philipp Riss
Journal:  Langenbecks Arch Surg       Date:  2022-01-21       Impact factor: 2.895

2.  Retrospective Analysis of Patients with Synchronous Primary Breast and Thyroid Carcinoma.

Authors:  İlker Murat Arer; Hakan Yabanoğlu; Murat Kuş; Aydıncan Akdur; Tevfik Avcı
Journal:  Eur J Breast Health       Date:  2018-04-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.